• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溴莫尼定调节ROCK1信号对二维和三维3T3-L1细胞脂肪生成分化的影响。

Brimonidine Modulates the ROCK1 Signaling Effects on Adipogenic Differentiation in 2D and 3D 3T3-L1 Cells.

作者信息

Umetsu Araya, Ida Yosuke, Sato Tatsuya, Watanabe Megumi, Tsugeno Yuri, Furuhashi Masato, Hikage Fumihito, Ohguro Hiroshi

机构信息

Department of Ophthalmology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.

Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.

出版信息

Bioengineering (Basel). 2022 Jul 19;9(7):327. doi: 10.3390/bioengineering9070327.

DOI:10.3390/bioengineering9070327
PMID:35877378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9311963/
Abstract

The additive effects of an α2-adrenergic agonist, brimonidine (BRI), on the pan-ROCK inhibitor (ROCK-i), ripasudil (Rip), and the ROCK2-I, KD025, on adipogenic differentiation (DIF+) were examined using two- or three-dimension (2D or 3D) cultures of 3T3-L1 cells. The following analyses were carried out: (1) lipid staining (2D and 3D), (2) real-time measurements of cellular metabolism (2D), (3) mRNA expression of DIF+ related genes and extracellular matrix molecules (ECMs) including collagen (Col)-1, -4, and -6, and fibronectin (Fn), and (4) the sizes and physical properties of the 3D spheroids. The findings indicate that DIF+ induced (1) a substantial enhancement in lipid staining and enhanced expression of the Pparγ and Fabp4 genes, (2) significantly larger and softer 3D spheroids, and (3) down-regulation of Col1 and Fn and up-regulation of Col4 and Col6 genes. Treatment with Rip alone caused a significant enhancement in adipogenesis of both the 2D and 3D cultured 3T3-L1 cells and in the physical properties of the 3D spheroids; these effects were substantially inhibited by BRI, and the effects induced by BRI or KD025 were not insignificant. These collective findings indicate that the addition of BRI inhibited the Rip-induced enhancement of DIF+ in 3T3-L1 cells, presumably by modulating ROCK1 signaling.

摘要

使用3T3-L1细胞的二维或三维(2D或3D)培养,研究了α2肾上腺素能激动剂溴莫尼定(BRI)对泛ROCK抑制剂(ROCK-i)瑞巴派特(Rip)以及ROCK2抑制剂KD025在脂肪生成分化(DIF+)方面的相加作用。进行了以下分析:(1)脂质染色(2D和3D),(2)细胞代谢的实时测量(2D),(3)DIF+相关基因和细胞外基质分子(ECM)的mRNA表达,包括胶原蛋白(Col)-1、-4和-6以及纤连蛋白(Fn),以及(4)3D球体的大小和物理性质。研究结果表明,DIF+诱导(1)脂质染色显著增强以及Pparγ和Fabp4基因表达增加,(2)3D球体明显更大且更软,以及(3)Col1和Fn基因下调,Col4和Col6基因上调。单独使用Rip处理导致2D和3D培养的3T3-L1细胞的脂肪生成以及3D球体的物理性质显著增强;这些作用被BRI显著抑制,并且BRI或KD025诱导的作用并非不显著。这些共同发现表明,添加BRI抑制了Rip诱导的3T3-L1细胞中DIF+的增强,可能是通过调节ROCK1信号传导实现的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154d/9311963/60412d79689e/bioengineering-09-00327-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154d/9311963/f6acadcfdef7/bioengineering-09-00327-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154d/9311963/a51405c30468/bioengineering-09-00327-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154d/9311963/4178dbc1f143/bioengineering-09-00327-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154d/9311963/57e15f2814c2/bioengineering-09-00327-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154d/9311963/0372e8e4c77e/bioengineering-09-00327-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154d/9311963/60412d79689e/bioengineering-09-00327-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154d/9311963/f6acadcfdef7/bioengineering-09-00327-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154d/9311963/a51405c30468/bioengineering-09-00327-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154d/9311963/4178dbc1f143/bioengineering-09-00327-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154d/9311963/57e15f2814c2/bioengineering-09-00327-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154d/9311963/0372e8e4c77e/bioengineering-09-00327-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154d/9311963/60412d79689e/bioengineering-09-00327-g006.jpg

相似文献

1
Brimonidine Modulates the ROCK1 Signaling Effects on Adipogenic Differentiation in 2D and 3D 3T3-L1 Cells.溴莫尼定调节ROCK1信号对二维和三维3T3-L1细胞脂肪生成分化的影响。
Bioengineering (Basel). 2022 Jul 19;9(7):327. doi: 10.3390/bioengineering9070327.
2
Unexpected Crosslinking Effects of a Human Thyroid Stimulating Monoclonal Autoantibody, M22, with IGF1 on Adipogenesis in 3T3L-1 Cells.人甲状腺刺激单克隆自身抗体 M22 与 IGF1 对 3T3L-1 细胞成脂分化的意外交联作用。
Int J Mol Sci. 2023 Jan 6;24(2):1110. doi: 10.3390/ijms24021110.
3
Simultaneous Use of ROCK Inhibitors and EP2 Agonists Induces Unexpected Effects on Adipogenesis and the Physical Properties of 3T3-L1 Preadipocytes.同时使用ROCK抑制剂和EP2激动剂对3T3-L1前脂肪细胞的脂肪生成和物理特性产生意想不到的影响。
Int J Mol Sci. 2021 Apr 28;22(9):4648. doi: 10.3390/ijms22094648.
4
Addition of EP2 agonists to an FP agonist additively and synergistically modulates adipogenesis and the physical properties of 3D 3T3-L1 sphenoids.将EP2激动剂添加到FP激动剂中,可对脂肪生成以及3D 3T3-L1蝶状体的物理特性产生累加和协同调节作用。
Prostaglandins Leukot Essent Fatty Acids. 2021 Aug;171:102315. doi: 10.1016/j.plefa.2021.102315. Epub 2021 Jul 3.
5
Addition of ROCK inhibitors to prostaglandin derivative (PG) synergistically affects adipogenesis of the 3D spheroids of human orbital fibroblasts (HOFs).加入 ROCK 抑制剂与前列腺素衍生物(PG)协同作用,影响人眼眶成纤维细胞(HOFs)3D 球体的脂肪生成。
Hum Cell. 2022 Jan;35(1):125-132. doi: 10.1007/s13577-021-00623-y. Epub 2021 Sep 30.
6
ROCK inhibitors modulate the physical properties and adipogenesis of 3D spheroids of human orbital fibroblasts in different manners.ROCK抑制剂以不同方式调节人眼眶成纤维细胞三维球体的物理特性和脂肪生成。
FASEB Bioadv. 2021 Jul 26;3(10):866-872. doi: 10.1096/fba.2021-00037. eCollection 2021 Oct.
7
Prostaglandin F2 and EP2 Agonists Exert Different Effects on 3D 3T3-L1 Spheroids during Their Culture Phase.前列腺素F2和EP2激动剂在其培养阶段对3D 3T3-L1球体发挥不同作用。
Biomedicines. 2021 Dec 2;9(12):1821. doi: 10.3390/biomedicines9121821.
8
Simultaneous Effects of a Selective EP2 Agonist, Omidenepag, and a Rho-Associated Coiled-Coil Containing Protein Kinase Inhibitor, Ripasudil, on Human Orbital Fibroblasts.选择性 EP2 激动剂奥美沙坦和 Rho 相关卷曲螺旋蛋白激酶抑制剂 ripasudil 对人眼眶成纤维细胞的协同作用。
J Ocul Pharmacol Ther. 2023 Sep;39(7):439-448. doi: 10.1089/jop.2023.0025. Epub 2023 Jun 23.
9
Addition of ROCK Inhibitors Alleviates Prostaglandin-Induced Inhibition of Adipogenesis in 3T3L-1 Spheroids.添加ROCK抑制剂可减轻前列腺素诱导的3T3L-1球体脂肪生成抑制。
Bioengineering (Basel). 2022 Nov 17;9(11):702. doi: 10.3390/bioengineering9110702.
10
Rosiglitasone and ROCK Inhibitors Modulate Fibrogenetic Changes in TGF-β2 Treated Human Conjunctival Fibroblasts (HconF) in Different Manners.罗格列酮和 Rho 激酶抑制剂以不同方式调节 TGF-β2 诱导的人结膜成纤维细胞(HconF)的纤维生成变化。
Int J Mol Sci. 2021 Jul 8;22(14):7335. doi: 10.3390/ijms22147335.

引用本文的文献

1
Advances in Organoid Research and Developmental Engineering.类器官研究与发育工程的进展
Bioengineering (Basel). 2024 Dec 15;11(12):1275. doi: 10.3390/bioengineering11121275.
2
Application of Single Cell Type-Derived Spheroids Generated by Using a Hanging Drop Culture Technique in Various Disease Models: A Narrow Review.利用悬滴培养技术生成的单细胞来源球体在各种疾病模型中的应用:一个简要综述。
Cells. 2024 Sep 14;13(18):1549. doi: 10.3390/cells13181549.
3
3D culture induction of adipogenic differentiation in 3T3-L1 preadipocytes exhibits adipocyte-specific molecular expression patterns and metabolic functions.

本文引用的文献

1
STAT3 Is the Master Regulator for the Forming of 3D Spheroids of 3T3-L1 Preadipocytes.STAT3 是 3T3-L1 前脂肪细胞形成 3D 球体的主调控因子。
Cells. 2022 Jan 16;11(2):300. doi: 10.3390/cells11020300.
2
Precision Medicine in Graves' Disease and Ophthalmopathy.格雷夫斯病与眼病中的精准医学
Front Pharmacol. 2021 Oct 28;12:754386. doi: 10.3389/fphar.2021.754386. eCollection 2021.
3
Addition of ROCK inhibitors to prostaglandin derivative (PG) synergistically affects adipogenesis of the 3D spheroids of human orbital fibroblasts (HOFs).
在3T3-L1前脂肪细胞中进行三维培养诱导脂肪生成分化,表现出脂肪细胞特异性分子表达模式和代谢功能。
Heliyon. 2023 Oct 5;9(10):e20713. doi: 10.1016/j.heliyon.2023.e20713. eCollection 2023 Oct.
4
Unraveling White Adipose Tissue Heterogeneity and Obesity by Adipose Stem/Stromal Cell Biology and 3D Culture Models.解析白色脂肪组织异质性与肥胖的脂肪干细胞/基质细胞生物学和 3D 培养模型。
Cells. 2023 Jun 8;12(12):1583. doi: 10.3390/cells12121583.
加入 ROCK 抑制剂与前列腺素衍生物(PG)协同作用,影响人眼眶成纤维细胞(HOFs)3D 球体的脂肪生成。
Hum Cell. 2022 Jan;35(1):125-132. doi: 10.1007/s13577-021-00623-y. Epub 2021 Sep 30.
4
Addition of EP2 agonists to an FP agonist additively and synergistically modulates adipogenesis and the physical properties of 3D 3T3-L1 sphenoids.将EP2激动剂添加到FP激动剂中,可对脂肪生成以及3D 3T3-L1蝶状体的物理特性产生累加和协同调节作用。
Prostaglandins Leukot Essent Fatty Acids. 2021 Aug;171:102315. doi: 10.1016/j.plefa.2021.102315. Epub 2021 Jul 3.
5
Prostaglandin F2α agonists induced enhancement in collagen1 expression is involved in the pathogenesis of the deepening of upper eyelid sulcus.前列腺素 F2α 激动剂诱导的胶原 1 表达增强参与了上睑沟加深的发病机制。
Sci Rep. 2021 Apr 26;11(1):9002. doi: 10.1038/s41598-021-88562-4.
6
ROCK inhibitors enhance the production of large lipid-enriched 3D organoids of 3T3-L1 cells.ROCK 抑制剂增强了 3T3-L1 细胞大脂质丰富 3D 类器官的产生。
Sci Rep. 2021 Mar 9;11(1):5479. doi: 10.1038/s41598-021-84955-7.
7
Prostaglandin F2α and EP2 agonists, and a ROCK inhibitor modulate the formation of 3D organoids of Grave's orbitopathy related human orbital fibroblasts.前列腺素 F2α 和 EP2 激动剂,以及 Rho 激酶抑制剂调节格雷夫斯眼病相关人眼眶成纤维细胞 3D 类器官的形成。
Exp Eye Res. 2021 Apr;205:108489. doi: 10.1016/j.exer.2021.108489. Epub 2021 Feb 12.
8
ROCK inhibitors beneficially alter the spatial configuration of TGFβ2-treated 3D organoids from a human trabecular meshwork (HTM).ROCK 抑制剂可有益地改变 TGFβ2 处理的来自人眼小梁组织(HTM)的 3D 类器官的空间构象。
Sci Rep. 2020 Nov 20;10(1):20292. doi: 10.1038/s41598-020-77302-9.
9
Prostaglandin F2α Agonists Negatively Modulate the Size of 3D Organoids from Primary Human Orbital Fibroblasts.前列腺素 F2α 激动剂可负调控原代人眼眶成纤维细胞 3D 类器官的大小。
Invest Ophthalmol Vis Sci. 2020 Jun 3;61(6):13. doi: 10.1167/iovs.61.6.13.
10
Prostaglandin F2α agonist-induced suppression of 3T3-L1 cell adipogenesis affects spatial formation of extra-cellular matrix.前列腺素 F2α 激动剂诱导的 3T3-L1 细胞脂肪生成抑制作用影响细胞外基质的空间形成。
Sci Rep. 2020 May 14;10(1):7958. doi: 10.1038/s41598-020-64674-1.